Joshua Ziel
Company: Aerami Therapeutics
Job title: Chief Operating Officer
Seminars:
[CASE STUDY]Optimization of Compound Delivery Through Different Devices 9:30 am
Discussing how the FDA sees the administered dose as the dose placed into the device, stressing the need to optimize compound delivery for accurate dosing Highlighting the importance of low delivery efficiency in some devices and its impact on safety margins, raising concerns about the effectiveness of the delivered drug Exploring how breath-actuated devices improve…Read more
day: Day 2
Chair’s Opening Remarks 8:45 am
day: Day 2
Chair’s Closing Remarks 4:15 pm
day: Day 2